Fred E. Cohen - 12 Jun 2024 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Reporting owner
Role
Director
Signature
James Basta, attorney-in-fact
Issuer context
Issuer symbol
NTLA
Transaction snapshot
Transactions as of
12 Jun 2024
Net transaction value
$0
SEC evidence
Form type
4
Filing time
14 Jun 2024, 16:19:29 UTC
Previous filing
28 May 2024
Next filing
20 Jun 2024
SEC filing
View on sec.gov

Key filing fact

Fred E. Cohen filed Form 4 for Intellia Therapeutics, Inc. (NTLA) on 14 Jun 2024.

Key facts

  • This page summarizes Fred E. Cohen's Form 4 filing for Intellia Therapeutics, Inc. (NTLA).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 14 Jun 2024, 16:19.

Change

  • Previous filing in this sequence was filed on 28 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

NTLA transaction

Common Stock

Award

Transaction value
$0
Shares
+7,737
Change %
+19%
Price
$0.000000
Shares after
49,453
Date
12 Jun 2024
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

NTLA transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+11,515
Change %
Price
$0.000000
Shares after
11,515
Date
12 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,515
Exercise price
$25.85
Footnotes
F2
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
F2 This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .